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Introduction
Rabies remains an important public health problem in the world due to uncontrolled enzootic rabies, lack of vaccines and poor information on the risk of contracting rabies after animal exposure. Globally there are over 70 000 cases of rabies reported each year. Rabies is now a re-emerging disease in several parts of the world including China where epidemics are currently exploding. Rabies virus (RABV), which is transmitted by bites of rabid animals, replicates in nervous tissues -only in neurons -, causing fatal encephalitis in nearly every case (1) . In the absence of post-exposure treatment, rabies is one of the very few human infections reaching a nearly 100 % mortality rate (2) . Recently, a spectacular and fortunate case of survival in the absence of rabies prophylaxis was reported (3) . Rabies recovery after obvious infection of the nervous system (NS) provides new hope that the striking evasive strategies of RABV (4, 5) can in some instances -and so far for unknown reasons -be disarmed. This urges us to investigate in depth how RABV infection modified human neuron physiology. It has been proposed that upregulation of immunoevasive molecules may contribute to the RABV strategy (6, 7) . Using an in silico analysis of the transcriptome of RABV infected human neurons, we managed to identify the co-inhibitor B7-H1 as a putative target of RABV to escape the host immune response.
T cell activation generally incorporates self-limiting mechanisms, such as inhibitory stimulation, to regulate T cell tolerance and attenuate the immune response. PD-1 (Programmed death 1) is one member of the inhibitory molecules belonging to the B7-CD28 which provide inhibitory functions to B and T cells. PD-1 expressed on T and B cells has two ligands, B7-H1 (alternatively programmed cell death ligand 1, PD-L1) and B7-DC (alternatively programmed cell death ligand 2, PD-L2). Ligation of PD-1 by B7-H1 inhibits T cell proliferation and cytokine production, leading to immunological tolerance in different immune compartments (8) (9) (10) (11) (12) (13) . B7-H1 is expressed under the control of IFN- (14) and IFN-4  (12). It is found on lymphoid tissues as well as in a variety of non-lymphoid tissues such as muscle, microvascular endothelial, renal tubular cells, ocular cells and in cancer cell lines (11, [14] [15] [16] [17] [18] [19] [20] . In the inflamed NS, microglia and macrophages were identified as the main sources of B7-H1 expression (11, 21) .
Ectopic expression of immune inhibitory B7-H1 by tumors serves as a mechanism for immune evasion (18, 22) . Viruses that specifically induce expression of B7-H1 or B7-DC in infected cells may down regulate the host immune response and favour infectiveness (19, 23) .
Blockade of the PD-1 pathway may augment antimicrobial immunity and diminish persistent infection in mice. This may lead to new ways of treating chronic viral infections in humans (8, 24) . Manipulation of the B7-H1/PD-1 pathway alters the course and severity of autoimmune NS inflammation in animal models of experimental allergic encephalomyelitis (21, 25, 26) .
Although B7-H1 is virtually absent from the non-infected NS (4, 7), we wondered whether modulation of B7-H1 could be employed by RABV to escape adverse host immune responses. We therefore investigated 1) whether B7-H1 was modulated in the NS of mice infected with RABV, 2) whether RABV-infected neurons express B7-H1 and 3) by using B7-
H1
-/-mice, whether the B7-H1 pathway contributes to RABV neuroinvasiveness. 
MATERIALS AND METHODS

Ab and reagents
Virus, human neural cells and mice
The laboratory RABV strain CVS (ATCC vr959), a highly pathogenic RABV strain (27) causing fatal encephalomyelitis in mice, was propagated as described (28) . HSV-1 strain KOS (29) was propagated on U373MG. B7-H1 -/-and TLR3 -/-mice were generated as described (30, 31) . Six-week-old C57Bl6 from Janvier (St. Berthevin, France), B7-H1 -/-or TLR-3 -/-female mice were inoculated intramuscularly in both hind legs, with 1x10 7 infectious particles of RABV. Disease progression was evaluated as described by scoring clinical signs and mortality (6) . Mobility and mortality were scored as follows: 0 = normal mice, 1 = ruffled fur, 2 = one paralysed hind leg, 3 = two paralysed hind legs, 4 = total paralysis (defined as the total loss of mobility) and 5 = death. Daily clinical score was obtained by adding individual 6 scores. Dead mice were reported in the clinical score of the day of the death and thereafter (cumulative scores). Disease progression was presented by a curve of cumulative clinical scores. At days 5, 7 and 9 after infection, groups of two or three mice were perfused. Spinal cords and brains were removed separately and stored at -80°C before being processed for RNA extraction, immunohistochemistry or mononuclear cell isolation by percol gradient.
Animal housing and experimental protocols followed guidelines approved by French Ministry of Agriculture and Ethical committee.
Human NT2-N neurons (32) and mixed cultures neurons/astrocytes, NT2-N/A (33) were differentiated from Ntera-2clD/1 cells as described (34, 35) . Purity of the NT2-N and mixed composition of NT2-N/A were checked by RT PCR as described (36) . Human neuroblastoma SK-N-SH cell lines (ATCC: HTB, cat N°11), SK-N-SH-CP, a natural mutant of SK-N-SH disabled for expression of IFN-, NT2-N and NT2-N/A cultures were infected with RABV or HSV-1 (7, 36) or treated for 24h and 48h with IFN-(1000 U), IFN (500 U)or TNF (1.25ng) when needed. Infection was detected by RT-PCR using primers directed against the HSV-1 UL54 gene or the RABV N gene amplicons and by immunocytochemistry as described (37) .
Cell cultures from mouse hippocampi prepared from embryos (C57Bl/6 mice) at stage E 18 as previously described (11) were incubated with cytokines (IFN- and- 500 U/ml and 1000 U/ml, respectively) for 48h.
Standard and real time RT-PCR
Total RNA was extracted with RNeasy kit (for cells) 24h after infection or cytokinetreatment, or with Lipid Tissue MidiKit (for nervous tissues). RNA quality was monitored using Agilent RNA chips. cDNA synthesis was performed with oligodT primers ( Table 1) . Real-time PCR was performed as described (11). Values were expressed as relative increase compared to normalized non-infected or non-treated control (value set to 1) according to the manufacturer's instructions.
Immunohistochemistry and immunocytochemistry
Dissected brains and spinal cords were snap frozen and embedded in tissue-Tek OCT.
Cryostat sections (8µm) were fixed in 4% Paraformaldehyde (PFA), permeabilized in SPB-0,5% Triton X-100, incubated with blocking buffer (5% goat serum and 2% BSA in SPB) and treated 1h at room temperature (Rt) with biotinylated anti-B7-H1 mouse mAb, then by Alexa Coverslips were mounted in Fluoromount-G and the samples observed under a Leica DM 5000B UV. Images were processed with the Leica FW 4000 software.
Cytofluorimetry for B7-H1 surface expression
Surface expression of B7-H1 was analyzed by flow cytometry. Gently scraped off infected and non-infected SK-N-SH were incubated with biotinylated B7-H1 specific mAb (clone MIH1, 2µg/10 6 cells) and then with FITC-conjugated streptavidin. Cells were analyzed by flow cytometry, using a BD Biosciences FACScalibur equipped with Cell Quest Pro software.
Specific fluorescence indices (SFIs) greater than 1.25 were considered positive.
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Phenotyping of splenocytes and mononuclear cells infiltrating the NS
CNS mononuclear cells were collected from homogenates of brain and spinal cord samples onto percoll gradients as described (37) . Splenocytes or mononuclear cells infiltrating the NS (10 5 in 50µl) were assessed by flow-cytometry using predetermined optimal concentrations of fluorescent pairs of mAb (CD3/CD19, CD4/CD3 and CD8/CD3). Data analysis was performed with Cell Quest Pro.
Measurement of T cells apoptosis in brain infiltrating T cells.
Morphological changes to identify cell in intermediate / late stages of apoptosis were assayed by side (SSC) and forward light scattering (FSC) flow cytometry analysis as previously described for T cells (38, 39) . Notably, B7-H1 protein expression was also up-regulated in cultures of mouse hippocampus neurons exposed to IFN or - for 48 h (Figure 2 ).
RESULTS
Activation
In the absence of IFN-expression, RABV does not trigger B7-H1 expression in human neural cell cultures
To test whether in the absence of IFN-, RABV can still upregulate B7-H1 expression, we used a human neuroblastoma cell line naturally disabled in the IFN expression (SK-N-SH-CP). We observed in these cells that in absence of IFN- signalling, RABV cannot upregulate B7-H1 expression anymore ( Figure 1E) , supporting strongly the role of IFN- in the control of B7-H1.
Expression and regulation of B7-H1 in the mouse NS after RABV infection
First, we monitored the expression and regulation of B7-H1 during NS infection by RABV by assessing brain and spinal cord specimens from animals at an early (day 5) and a late stage of infection (day 7) using real time RT-PCR as well as immunohistochemistry. As expected (11), B7-H1 mRNAs were virtually undetectable in the non-infected NS. In contrast, B7-H1 mRNA expression progressively increased during the course of infection and correlated with the invasion of spinal cord and brain by the virus (Figure 3A) . In order to identify the cellular source of B7-H1, we performed double immuno-staining analysis detecting infected neurons 
Contribution of B7-H1 to immune evasion in RABV infection
We found that RABV specifically triggers the regulation and the surface expression of B7-H1 in infected neurons. Various reports have demonstrated that B7-H1 provides an inhibitory signal in the interaction with antigen-specific T-cells. Importantly, B7-H1 is responsible for the exhaustion of antiviral T cell responses by triggering the anergy of activated T cells (19) .
We therefore tested whether this key molecule was involved in the immunoevasive strategy of RABV. To do so, we compared the progression and the outcome of RABV infection in mice RABV was also less severe in TLR3 -/-mice than in WT mice (mortality was reduced by a two-fold factor, 63% mortality in WT versus 34% mortality in TLR3 -/-mice; data not shown).
Of note, as shown in Figure 4 , B7-H1 was less transcribed in neural tissues of RABV infected TLR3 -/-mice than in WT mice.
CD8 + T cell infiltration into the RABV infected NS is maintained in the absence of B7-
H1
We previously observed that the severity of RABV infection was inversely correlated with the number of CD3 + and CD8 + T cells in the NS (6, 37) . Conclusions of these previous studies were that highly neuroinvasive and pathogenic infections were associated with a severe drop in the number of CD3 + T cells of migratory cells into the NS, whereas high amounts of CD3 
Invasion of CD3 + T cells was observed already at day 5. No difference was found between
WT and B7-H1 -/-mice (CD3 + T cells represented 55% of the migratory cells in WT and 62%
in B7-H1 -/-NS). As described previously (6), the pool of migratory CD3 + T cells in the WT NS dropped later (here at day 10 post infection; Figure 6A ). This decrease of CD3 + T cells was mainly due to a drastic disappearance of CD8 + T cells (CD8 + T cells represents only 3%
of the CD3 + T cells migratory pool), whereas the pool of CD4 + T cells is more stable ( Figure 6B and 6C). The drop of CD8 + T cells might account for the increase of the CD4/CD8 ratio which rises from 2.9 at day 5 up to 5.8 at day 10 ( Figure 6D) . In striking contrast to WT mice, neither the decrease of CD3 + T cell at day 10, nor the CD8 + T cell decrease were observed in infected B7-H1 -/-mice ( Figure 6A and B) . results also stress a specific and important aspect of RABV infection, its "organ-specificity".
Here, the B7-H1/PD1-pathway is specifically manipulated upon infection in the NS.
Expression of B7-H1 is modulated in this organ as well as B7-H1 induced changes in CD4/CD8 ratio in the NS. This takes place despite the fact that no change in the CD4/CD8 ratio occurred in the periphery and despite the fact that WT mice as well as B7-H1 -/-mice develop similar RABV specific serum antibodies (data not shown), strongly suggesting that mounting of primary immune response against RABV was not altered by the absence of B7-H1. We can conclude that it is the specific B7-H1 over-expression in the RABV infected NS which contributes to the immunoevasiveness of the virus. However, among neuronotropic viruses, up-regulation of B7-H1 could not be shared by every virus since, as reported here, HSV-1 did not alter B7-H1 expression and only partially counteracts and escapes the host immune responses (7).
We observed that mice lacking TLR3 showed a reduced B7-H1 expression, suggesting that transcription, since HSV-1 strictly inhibits host IFN response (36, 56) . It is surprising that B7-H1 expression in TLR3 -/-brains was still reduced despite the production of large amounts of IFN- transcripts in these tissues. This may indicate that -at least in vivo -B7-H1 expression requires a production of IFN- and  above a certain threshold and/or that synergetic effects between the two cytokines are required.
In any case, these observations suggest that B7-H1 up-regulation in the NS occurs as a response to or in the presence of a specific "inflammatory" cytokine milieu (11). In the instance of autoimmune NS inflammation, expression of B7-H1 is localized within areas of strongest inflammation and is considered to act as a "negative" regulatory feedback loop for keeping the "anti-inflammatory milieu" in the NS (4) . Such a tissue tolerance function of B7-H1 has similarly been postulated in other parenchymateous organs, as recently shown for the pancreas in a disease model of autoimmune diabetes (9, 10) . While the inhibitory function of tissue related B7-H1 is beneficial in the instance of (autoimmune) inflammatory aggression, it has opposite effects in the case of viral infection: here, the virus diverts a feed back loop to its own strategy. In the case of RABV, a pathogen well-adapted to the NS, we propose that B7-H1 acts as a viral target for immune evasion.
Our data support a sequential scheme of events after NS infection by RABV contributing to 
